GlassScriptPhysician profile
Sonia Qadir
NPI 1417973082
$2,792.18
in general payments reported to CMS, 2019-2025
25 companies · $706 in 2025
The $706 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $211 · 2021: $314 · 2022: $424 · 2023: $305 · 2024: $476 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,487.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $661.13 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $378.28 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $360.94 | 2020-2025 | |
| Abbvie INC. | $247.95 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $195.48 | 2021-2024 | Farxiga, Airsupra |
| Allergan, INC. | $164.50 | 2019 | |
| Amgen INC. | $126.95 | 2023-2025 | Repatha, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $84.06 | 2019-2021 | |
| Abbott Laboratories | $77.19 | 2022-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.43 | 2023-2024 | Ofev |
| Dexcom, INC. | $53.43 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $44.81 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.33 | 2025 | |
| Genentech USA, INC. | $34.22 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $33.79 | 2025 | Purified Cortrophin Gel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $27.46 | 2022 | |
| Inspire Medical Systems, INC. | $27.44 | 2025 | Inspire |
| Exact Sciences Corporation | $26.59 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $24.96 | 2024 | Thinprep 2000 Processor |
| Lundbeck LLC | $23.54 | 2025 | Rexulti |
| Astellas Pharma US INC | $21.07 | 2019 | |
| Renalytix Ai, INC. | $20.72 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Qiagen, LLC | $18.87 | 2021 | |
| Seqirus USA INC | $14.72 | 2019 | |
| Medicure Pharma INC. | $13.32 | 2025 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Qadir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.